IL1B and COVID-19: Furthermore, we demonstrate for the first time that higher GCF IL-1β levels elevate COVID-19 risk, suggesting a novel mechanism through which SARS-CoV-2 might cause an individual onset of COVID-19 through the IL-1β-related pathways.